Literature DB >> 7814556

Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients.

M M Aspin1, G M Gallez-Hawkins, T D Giugni, B Tegtmeier, D J Lang, G M Schmidt, S J Forman, J A Zaia.   

Abstract

Plasma PCR for human cytomegalovirus (CMV) DNA was compared with bronchoalveolar lavage (BAL) fluid culture as an indicator for disseminated CMV infection. Thirteen (32.5%) of 40 consecutive bone marrow transplant (BMT) recipients were BAL fluid culture positive for CMV on day 35 post-BMT, and 9 (69%) of the 13 had positive plasma PCRs between days 28 and 49. Of the 27 with negative BAL fluid cultures, 2 (7%) had positive plasma PCRs (P < 0.001). Plasma CMV DNA in BMT recipients is a useful clinical marker for serious infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814556      PMCID: PMC263979          DOI: 10.1128/jcm.32.9.2266-2269.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.

Authors:  J D Meyers; E C Reed; D H Shepp; M Thornquist; P S Dandliker; C A Vicary; N Flournoy; L E Kirk; J H Kersey; E D Thomas
Journal:  N Engl J Med       Date:  1988-01-14       Impact factor: 91.245

2.  Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia.

Authors:  P Ruutu; T Ruutu; L Volin; P Tukiainen; P Ukkonen; T Hovi
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

Review 3.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens.

Authors:  C A Gleaves; T F Smith; E A Shuster; G R Pearson
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

5.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

6.  Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification.

Authors:  G J Demmler; G J Buffone; C M Schimbor; R A May
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

Review 7.  Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

8.  Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma.

Authors:  D G Wolf; S A Spector
Journal:  Transplantation       Date:  1993-08       Impact factor: 4.939

9.  Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution.

Authors:  J R Wingard; E D Mellits; M B Sostrin; D Y Chen; W H Burns; G W Santos; H M Vriesendorp; W E Beschorner; R Saral
Journal:  Medicine (Baltimore)       Date:  1988-05       Impact factor: 1.889

10.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes.

Authors:  W van der Bij; R Torensma; W J van Son; J Anema; J Schirm; A M Tegzess; T H The
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

View more
  9 in total

1.  A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence.

Authors:  R Boom; C Sol; J Weel; Y Gerrits; M de Boer; P Wertheim-van Dillen
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects.

Authors:  G Boivin; J Handfield; E Toma; G Murray; R Lalonde; V J Tevere; R Sun; M G Bergeron
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

3.  Evaluation of a quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients.

Authors:  G M Gallez-Hawkins; B R Tegtmeier; A ter Veer; J C Niland; S J Forman; J A Zaia
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 4.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

5.  Monitoring of leukocyte cytomegalovirus DNA in bone marrow transplant recipients by nested PCR.

Authors:  K Y Yuen; S K Lo; E K Chiu; S S Wong; Y L Lau; R Liang; T K Chan; M H Ng
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

6.  Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.

Authors:  S A Spector; R Wong; K Hsia; M Pilcher; M J Stempien
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

7.  Quantitation of cytomegalovirus (hCMV) DNA and beta-actin DNA by duplex real-time fluorescence PCR in solid organ (liver) transplant recipients.

Authors:  Joachim Hänfler; Karl Anton Kreuzer; Katja Laurisch; Nada Rayes; Peter Neuhaus; Christian Andreas Schmidt; Helmut Oettle
Journal:  Med Microbiol Immunol       Date:  2003-01-30       Impact factor: 3.402

Review 8.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

9.  High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation.

Authors:  R Nakamura; K Cortez; S Solomon; M Battiwalla; V J Gill; N Hensel; R Childs; A J Barrett
Journal:  Bone Marrow Transplant       Date:  2002-08       Impact factor: 5.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.